Health Research Alliance
2008 EN.pdf (787.18 kB)
Download file

2008 EN.pdf

Download (787.18 kB)
journal contribution
posted on 2019-03-04, 21:52 authored by Ning Chen, Michael Chopp, Ye Xiong, Jian-Yong Qian, Mei Lu, Dong Zhou, Zhongwu LiuZhongwu Liu
In addition to thrombolysis, tissue plasminogen activator (tPA) can evoke neurorestorative processes. We
therefore investigated the therapeutic effect of subacute intranasal administration of tPA post stroke on neurological
recovery and on corticospinal innervation in mice. A transgenic mouse line, in which the pyramidal
neurons and corticospinal tract (CST) axons are specifically labeled by yellow fluorescent protein (YFP) was
employed. Adult CST-YFP mice were subjected to right unilateral middle cerebral artery occlusion (MCAo), and
were randomly divided into groups treated with saline or tPA intranasally in the subacute phase. Pseudorabies
virus (PRV)-614-monomeric red fluorescent protein (RFP) was injected into the left forelimb. The cervical spinal
cord and brain were processed for fluorescent microscopy to detect YFP and RFP labeling. Primary embryonic
neurons were cultured with tPA at different concentrations. Neurite length and branch numbers were then
measured. In vivo, subacute tPA treatment significantly enhanced functional recovery (p < 0.05), and increased
CST density in the denervated gray matter, and in the numbers of PRV-labeled neurons in bilateral cortices. The
behavioral performance was significantly correlated with axonal density in the denervated spinal cord. In vitro,
both neurite length and branch numbers significantly increased with concentration of tPA (p < 0.05). Our
results demonstrate that tPA dose-dependently increases neurite outgrowth and branching of cultured cortical
neurons. Subacute intranasal administration of tPA may provide enhance neurological recovery after stroke by
promoting CST axonal remodeling.


Grant ID